12th Annual IBA World Life Sciences Conference Pestana Palace Lisboa, The Leading Hotels of the World, Lisboa

Subjects include:

– Clinical trials: current trends and perspectives at a global level
– Data exclusivity/Bolar – the EU Pharma Package and other jurisdictions
– Antitrust and intellectual property – divisionals, patent settlements, unlawful PTEs and PTAs
– Preventive health and longevity: legal perspectives shaping the future of healthcare
– Cross-border intellectual property litigation
– Integration of pharma and MedTech with hospitals, clinics and pharmacies
– Liability and accountability in open science research
– Combination products (drug-device) regulation: emerging legal complexities
– Preparing for the entry into force of the WIPO GRATK Treaty
– Artificial intelligence and biotechnology: rethinking patent standards
– AI and data rights in life sciences and HealthTech deals (training data, model outputs and infringement risk)
– Collaboration and licensing structures as financing tools
– Life sciences M and A in uncertain markets – earnouts, contingent value rights, contingent milestones and intellectual property-driven valuation mechanics
– Late-stage private financings and IPO alternatives (crossovers, structured preferred, PIPEs, ATMs, registered directs)
– Cross-border investment constraints affecting financings and exits (CFIUS risk, sensitive health/genomic data and closing conditions)